Lipid Forum-1
|
13:30-15:30 402 |
|---|
| 主持 Moderators | 毛威 Wei MAO, 梁春 Chun LIANG, 余锂镭 Lilei YU, 高超 Chao GAO, 李晖 Hui LI | ||
|
13:30-13:40 |
致辞 Opening Remarks |
||
|
13:40-13:45 |
“心未来菁英汇”心血管中青年医师发展计划-启动仪式 Heart Future Elite Forum" Cardiovascular Mid-Career Physician Development Program - Launch Ceremony |
||
|
13:45-13:50 |
中青年医师发展计划项目介绍 Introduction to the Mid-career Physician Development Program |
定 待 | |
|
13:50-14:10 |
新机制-血脂干预新靶点的研究进展 Novel Mechanisms-Research Progress on New Therapeutic Targets for Lipid Intervention |
杜常青 Changqing DU | |
|
14:10-14:30 |
浅析中国动脉粥样硬化负担，求索斑块筛查评估 A Brief Analysis of Atherosclerosis Burden in China and Exploration of Plaque Screening and Assessment |
赵然尊 Ranzun ZHAO | |
|
14:30-14:50 |
2025+ESC+热点速递：探讨个体化血脂管理策略 2025 ESC Highlights: Exploring Personalized Strategies for Lipid Management |
史宏涛 Hongtao SHI | |
|
14:50-15:10 |
CCS患者的规范化药物治疗策略探索 Investigation of Standardized Drug Therapy Strategies in CCS Patients |
陈翔 Xiang CHEN | |
|
15:10-15:30 |
ASCVD残余炎症风险控制：路在何方 ASCVD Residual Inflammatory Risk Management: Where Do We Go from Here? |
戴宇翔 Yuxiang DAI | |
Lipid Forum-2
|
15:30-17:30 402 |
|---|
| 主席 Chairman | 王建安 Jianan WANG | ||
| 主持 Moderators | 胡新央 Xinyang HU, 吴高俊 Gaojun WU, 叶红华 Honghua YE, 胡惠林 Huilin HU | ||
| 讨论嘉宾 Discussants | 汪云开 Yunkai WANG, 罗骏 Jun LUO, 陈长弓 Changgong CHEN, 陈丽娜 Lina CHEN | ||
|
15:30-15:40 |
主席致辞 Opening Remarks |
定 待 | |
|
15:40-16:00 |
ASCVD的一级及二级预防 Primary and Secondary Prevention of ASCVD |
吕玲春 Lingchun LV | |
|
16:00-16:20 |
胆固醇吸收抑制剂的药学特性和临床应用 Cholesterol Absorption Inhibitors: Pharmacology and Clinical Use |
江波 Bo JIANG | |
|
16:20-16:40 |
降胆固醇药物的研究沿革 The Evolution of Research on Cholesterol-lowering Drugs |
杨文艺 Wenyi YANG | |
|
16:40-17:00 |
ACS患者血脂管理策略探讨-逐级序贯降脂治疗的关键作用 Exploring Lipid Management Strategies for ACS Patients: The Critical Role of Stepwise Sequential Lipid-Lowering Therapy |
陈铁龙 Tielong CHEN | |
|
17:00-17:20 |
ACS患者血脂管理策略探讨-起始联合降脂治疗的关键作用 Exploring Lipid Management Strategies for ACS Patients: The Critical Role of Initial Combination Lipid-Lowering Therapy |
金重赢 Zhongying JIN | |
|
17:20-17:30 |
讨论 Discussion |
||
Antithrombotic Forum-3
|
08:00-10:00 402 |
|---|
| 主持 Moderators | 王贵松 Guisong WANG, 唐欧杉 Oushan TANG, 马盛辉 Shenghui MA, 徐曌 Zhao XU, 齐玉波 Yubo QI | ||
|
08:00-08:20 |
从指南变迁看冠心病个体化抗栓的发展趋势 Development Trend of Individualized Antithrombosis in Coronary Heart Disease from the Perspective of Guideline Changes |
钱菊英 Juying QIAN | |
|
08:20-08:40 |
PCI术后抗血小板治疗的最新研究 Latest Research on Antiplatelet Therapy After PCI |
马依彤 Yitong MA | |
|
08:40-09:00 |
冠心病合并房颤患者的抗栓治疗 Antithrombotic Treatment in Patients with Coronary Heart Disease Complicated with Atrial Fibrillation |
苑海涛 Haitao YUAN | |
|
09:00-09:20 |
特殊人群的房颤抗凝治疗 Atrial Fibrillation Anticoagulation in Special Populations |
孟照辉 Zhaohui MENG | |
|
09:20-09:40 |
高出血风险患者PCI术后超短期DAPT策略 Ultra-Short-Term DAPT Strategy After PCI in Patients at High Bleeding Risk |
张邢炜 Xingwei ZHANG | |
|
09:40-10:00 |
2025 抗栓治疗新视野：从国际指南到临床实践 2025 New Perspective on Antithrombotic Treatment: From International Guidelines to Clinical Practice |
程科云 Keyun CHENG | |
Antithrombotic Forum-4
|
10:00-12:00 402 |
|---|
| 主持 Moderators | 袁祖贻 Zuyi YUAN, 韩清华 Qinghua HAN, 李妍 Yan LI, 钟泽 Ze ZHONG, 王卫国 Weiguo WANG, 吴少琴 Shaoqin WU | ||
|
10:00-10:20 |
最新的 PCI 围术期规范化抗栓的治疗策略 Latest Standardized Antithrombotic Treatment Strategy During PCI Perioperative Period |
贾绍斌 Shaobin JIA | |
|
10:40-11:00 |
2025中国心房颤动管理指南解读 Interpretation of the 2025 Chinese Guidelines for the Management of Atrial Fibrillation |
江力勤 Liqin JIANG | |
|
11:00-11:20 |
肾功能不全患者的抗栓治疗策略 Antithrombotic Treatment Strategies for Patients with Renal Insufficiency |
陈晓敏 Xiaomin CHEN | |
|
11:20-11:40 |
泛血管疾病抗栓治疗：探索个体化治疗策略 Antithrombotic Treatment of Pan-Vascular Diseases: Exploring Individualized Treatment Strategies |
唐礼江 Lijiang TANG | |
|
11:40-12:00 |
VTE合并冠心病抗栓策略 Antithrombotic Strategy for VTE Complicated with Coronary Heart Disease |
董鹏 Peng DONG | |
Heart Failure Forum-2
|
13:30-15:30 402 |
|---|
| 主持 Moderators | 马学平 Xueping MA, 陈丽娜 Lina CHEN, 卢孔杰 Kongjie LU, 吕玲春 Lingchun LV, 廉姜芳 Jiangfang LIAN | ||
|
13:30-13:50 |
心衰合并症的管理 Management of Heart Failure Comorbidities |
黎励文 Liwen LI | |
|
13:50-14:10 |
应早尽早——从心衰治疗目标看预防进展的意义 Early Intervention is Essential - Significance of Prevention Progress from the Perspective of Heart Failure Treatment Goals |
陈爱兰 Ailan CHEN | |
|
14:10-14:30 |
中国心衰治疗和指南更新要点（2024） Key Points of Chinese Heart Failure Treatment and Guideline Updates (2024) |
谢伟 Wei XIE | |
|
14:30-14:50 |
从发病机制看心梗后心衰患者优化治疗新选择 Novel Therapeutic Options for Optimizing Management of Heart Failure after Myocardial Infarction: A Pathophysiological Perspective |
李为民 Weimin LI | |
|
14:50-15:10 |
HFrEF合并低血压临床处理策略 Clinical Management Strategy for HFrEF Complicated with Hypotension |
罗素新 Suxin LUO | |
|
15:10-15:30 |
心衰患者的血压管理 Blood Pressure Management in Heart Failure Patients |
李萍 Ping LI | |
Heart Failure Forum-3
|
15:30-17:30 402 |
|---|
| 主持 Moderators | 李为民 Weimin LI, 姜萌 Meng JIANG, 李萍 Ping LI, 金奇志 Qizhi JIN, 蔡元生 Yuansheng CAI | ||
|
15:30-15:50 |
右心导管在心力衰竭中的应用 Application of Right Heart Catheterization in Heart Failure |
徐东杰 Dongjie XU | |
|
15:50-16:10 |
重视心衰合并心肌肥厚的病因解析 Emphasis on Etiological Analysis of Heart Failure Complicated with Myocardial Hypertrophy |
金玮 Wei JIN | |
|
16:10-16:30 |
心衰患者的利尿剂抵抗的应对策略 Coping Strategies for Diuretic Resistance in Heart Failure Patients |
王江 Jiang WANG | |
|
16:30-16:50 |
射血分数改善心衰的现状与管理 Current Status and Management of Heart Failure with Improved Ejection Fraction |
袁璟 Jing YUAN | |
|
16:50-17:10 |
利钠肽系统在心衰全生命周期的作用 Role of the Natriuretic Peptide System in the Whole Life Cycle of Heart Failure |
毛威 Wei MAO | |
|
17:10-17:30 |
讨论 Discussion |
||
Heart Failure Forum-4
|
08:00-10:00 402 |
|---|
| 主持 Moderators | 杨杰孚 Jiefu YANG, 周京敏 Jingmin ZHOU, 黄进宇 Jinyu HUANG, 许洁伟 Jiewei XU, 张瑶 Yao ZHANG, 应淑琴 Shuqin YING | ||
|
08:00-08:20 |
HFpEF（射血分数保留性心衰）治疗的最新进展 State-of-the-Art Lecture in theTreatment of HFpEF |
Carolyn LAM | |
|
08:20-08:40 |
终末期心衰的姑息治疗 Palliative Care for End-Stage Heart Failure |
李凌 Ling LI | |
|
08:40-09:00 |
血糖管理与心衰治疗策略 Blood Glucose Management and Heart Failure Treatment Strategy |
杜贝贝 Beibei DU | |
|
09:00-09:20 |
心衰中心质控考核方案与质控标准&浙江省质控报告 Quality Control Assessment Plan and Standards for Heart Failure Centers & Zhejiang Provincial Quality Control Report |
项美香 Meixiang XIANG | |
|
09:20-09:40 |
从国内外最新指南看心衰高钾血症管理 Management of Heart Failure-Associated Hyperkalemia from the Latest Domestic and International Guidelines |
董蔚 Wei DONG | |
|
09:40-10:00 |
心肌病合并心衰的猝死预防进展 Progress in Sudden Cardiac Death Prevention in Cardiomyopathy Complicated with Heart Failure |
姜萌 Meng JIANG | |
Heart Failure Forum-5
|
10:00-12:00 402 |
|---|
| 主持 Moderators | 王利宏 Lihong WANG, 许轶洲 Yizhou XU, 杨伊萍 Yiping YANG, 刘艳梅 Yanmei LIU | ||
|
10:00-10:20 |
2025ESC-Hotline VICTOR研究解读： sGC刺激剂在HFrEF患者全程管理中的突破性价值 Interpretation of the 2025 ESC-Hotline VICTOR Study: Breakthrough Value of sGC Stimulants in the Whole-Course Management of HFrEF Patients |
周京敏 Jingmin ZHOU | |
|
10:20-10:40 |
正性肌力药物在终末期心衰中的应用 Application of Inotropic Drugs in End-Stage Heart Failure |
张瑶 Yao ZHANG | |
|
10:40-11:00 |
心力衰竭容量管理评估技术进展与意义 Progress and Significance of Volume Management Assessment Technology in Heart Failure |
盛莉 Li SHENG | |
|
11:00-11:20 |
从指南变迁看心衰治疗策略新趋势 New Trends in Heart Failure Treatment Strategies from the Perspective of Guideline Changes |
王留义 Liuyi WANG | |
|
11:20-11:40 |
一例肿瘤药物相关心力衰竭的诊疗实践 Diagnostic and Therapeutic Practice of a Case of Tumor Drug-Related Heart Failure |
李兴红 Xinghong LI | |
|
11:40-12:00 |
讨论 Discussion |
||